ResMed
RMD
667 hedge funds and large institutions have $21.1B invested in ResMed in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 222 increasing their positions, 255 reducing their positions, and 60 closing their positions.
122% more call options, than puts
Call options by funds: $61.3M | Put options by funds: $27.7M
4% more capital invested
Capital invested by funds: $20.3B → $21.1B (+$764M)
0% more funds holding in top 10
Funds holding in top 10: 15 → 15 (0)
0.24% less ownership
Funds ownership: 66.02% → 65.78% (-0.24%)
3% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 60
1% less funds holding
Funds holding: 676 → 667 (-9)
13% less repeat investments, than reductions
Existing positions increased: 222 | Existing positions reduced: 255
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$99M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$64.3M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$46.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.5M |
| 5 |
JP Morgan Chase
New York
|
+$38.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$136M |
| 2 |
IIM
INTECH Investment Management
West Palm Beach,
Florida
|
-$97M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$52.1M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$34M |
| 5 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$26.4M |
RMD Hedge Fund Activity: Q3 2022 in Review
667 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2022, worth a combined $21.1B — up 3.8% from $20.3B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of RMD and 58 opened new positions — a net loss of 2 holders — while 255 trimmed existing stakes and 222 added.
The largest buyer was Capital World Investors, adding an estimated $99M. The largest seller was WCM Investment Management, cutting an estimated $136M.
- 667 institutional investors held ResMed (RMD) as of Q3 2022, down from 676 in Q2 2022.
- Funds reported $21.1B of ResMed stock for Q3 2022, up 3.8% quarter-over-quarter.
- 58 funds opened new ResMed positions in Q3 2022 and 60 closed out, a net change of -2 holders.
- The largest ResMed buyer in Q3 2022 was Capital World Investors, an estimated $99M added.
- The largest ResMed seller in Q3 2022 was WCM Investment Management, an estimated $136M sold.
Based on aggregated 13F filings for Q3 2022.